Prof. Dr. Georg Schett is one of the world’s foremost experts in rheumatoid arthritis and cell therapy for autoimmune diseases. He is Vice President of Research and Head of Department of Internal Medicine 3 at Friedrich-Alexander-Universität Erlangen-Nürnberg, where his research interests include basic, translational, and clinical research on the molecular and cellular pathogenesis of rheumatic and autoimmune diseases. Notably, his leadership in the field includes projects such as the priority program IMMUNOBONE, the DFG CRC1181 “Checkpoints for Resolution of Inflammation,” the METARTHROS project investigating the impact of metabolism on arthritis, the ERC Synergy Grant (4D+ NanoSCOPE), and the BMBF funding project, “MASCARA” (Molecular Assessment of Signatures Characterizing the Remission of Arthritis). In 2022, he also reported on the transformative nature of anti-CD19 CAR T-cell therapy for refractory systemic lupus.

Dr. Schett has published more than 820 peer-reviewed papers, and, as an expert in his field, has been invited to over 660 congresses and conferences.  He has received numerous awards and honors for his outstanding contributions to rheumatology, including the Dr. Franciscus Blondel Medal from the city of Aachen, the Carol-Nachman Prize from Wiesbaden, and the 2023 Gottfried Wilhelm Leibniz Prize. He became a Leopoldina member of the National Academy of Sciences of Germany in 2021, and serves as a member of the German Research Foundation (DFG) review board. In addition to multiple visiting professorships around the globe, Dr. Schett is a reviewer for several academic societies and journals, and a collaborator in organizing numerous international congresses.  

Dr. Schett earned his medical degree from the University of Innsbruck in Austria, and completed his specialty training in internal medicine and rheumatology at the University of Vienna.